NextCure, Inc. (NXTC) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Join SI Premium – FREE
NextCure, Inc. (NASDAQ: NXTC) reported Q1 EPS of ($0.61), $0.17 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
